From the Guidelines
A creatinine level of 1.62 mg/dL may indicate acute kidney injury (AKI), depending on the individual's baseline creatinine level. For most adults, normal creatinine ranges from 0.7-1.3 mg/dL, so 1.62 mg/dL is elevated. AKI is typically defined as an increase in serum creatinine by ≥0.3 mg/dL within 48 hours or a 50% increase from baseline within 7 days, as stated in the study by 1. If this represents a significant increase from your baseline, it should be evaluated promptly. Management includes identifying and treating the underlying cause, maintaining adequate hydration, avoiding nephrotoxic medications, and monitoring fluid balance and electrolytes. Common causes of AKI include dehydration, medication effects, infection, or obstruction of the urinary tract. A healthcare provider should evaluate this creatinine level in the context of your medical history, other laboratory values, and clinical condition. Some key points to consider in the evaluation of AKI include:
- The definition of AKI, which includes an increase in serum creatinine by ≥0.3 mg/dL within 48 hours or a 50% increase from baseline within 7 days, as noted in the study by 1
- The importance of identifying and treating the underlying cause of AKI, as discussed in the study by 2
- The need to maintain adequate hydration, avoid nephrotoxic medications, and monitor fluid balance and electrolytes, as recommended in the study by 1
- The potential for AKI to progress to chronic kidney disease (CKD) or end-stage renal disease (ESRD), as highlighted in the study by 3. Overall, a creatinine level of 1.62 mg/dL should be taken seriously and evaluated promptly to determine the underlying cause and appropriate management.
From the Research
Definition of Acute Kidney Injury (AKI)
- Acute kidney injury (AKI) is defined by a sudden loss of excretory kidney function 4.
- AKI is characterized by abrupt deterioration in kidney function, manifested by an increase in serum creatinine level with or without reduced urine output 5.
Diagnosis of AKI
- The diagnostic evaluation can be used to classify AKI as prerenal, intrinsic renal, or postrenal 5.
- The initial workup includes a patient history to identify the use of nephrotoxic medications or systemic illnesses that might cause poor renal perfusion or directly impair renal function 5.
- The initial laboratory evaluation should include measurement of serum creatinine level, complete blood count, urinalysis, and fractional excretion of sodium 5.
Creatinine Levels and AKI
- Creatinine levels drift in patients with chronic kidney disease (CKD), causing false positives in AKI detection without adjustment 6.
- A novel equation can adjust the most recent creatinine value for drift over time, providing more accurate baseline creatinine estimation in patients with suspected AKI on CKD 6.
- The equation improved AKI event reclassification by an additional 2.5% compared to the unadjusted most recent creatinine value and 7.3% compared to the CKD-EPI 2021 back-estimation equation 6.
Management of AKI
- Management of AKI involves fluid resuscitation, avoidance of nephrotoxic medications and contrast media exposure, and correction of electrolyte imbalances 5.
- Renal replacement therapy (dialysis) is indicated for refractory hyperkalemia; volume overload; intractable acidosis; uremic encephalopathy, pericarditis, or pleuritis; and removal of certain toxins 5.
- Conservative management should first be attempted for patients with AKI, and if conservative management fails, renal replacement therapy or hemodialysis can be used 7.